| Code | 9266C | ||||||||||
| MA number | EU/1/18/1311/001 | ||||||||||
| Product Form: | tbl flm 180x40 mg (fľ.HDPE) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 31.08.2018 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
NERLYNX_Prirucka_pre_zdravotnickych_pracovnikov.pdf
|
| Dokument: |
NERLYNX_Dennik_liecby_pacienta_.pdf
|
| Dokument: |
NERLYNX_Prirucka_k_liecbe_pre_pacienta_opatrovatela.pdf
|
| Safety feature | Yes |
| Data update: | 07.06.2023 |
